ApicHope Pharmaceutical Group Co., Ltd. (SZSE: 300723)
Health Care · Pharmaceuticals · CN
CN¥36.75
-5.09% today · -47.1% 1Y
ApicHope Pharmaceutical Group Co., Ltd. (SZSE: 300723) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $2.45B and employs 1,294 people.
Over the last twelve months the share price has lost 47.1%, trading between 29.31 and 76.88.
Tweenvest scores ApicHope Pharmaceutical Group Co., Ltd. across four factors: quality 58/100, value 30/100, growth 0/100. Its strongest factor is quality.
300723 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $2.45B
- Revenue (TTM)
- $136.40M
- P/E
- 83.01
- EPS
- 0.44
- Dividend yield
- —
- Beta (5Y)
- 0.77
- 52-week high
- CN¥76.88
- 52-week low
- CN¥29.31
- Avg volume (3M)
- —
- Shares outstanding
- 448.53M
- Employees
- 1,294
- Next earnings
- —
About ApicHope Pharmaceutical Group Co., Ltd.
ApicHope Pharmaceutical Co., Ltd, along with its various subsidiary entities, operates primarily in the pharmaceutical sector, focusing on the research, development, production, and distribution of medicinal products. The company boasts an extensive portfolio of offerings that address diverse therapeutic needs, including solutions for infectious diseases, pediatric health, cardiovascular conditions, genitourinary disorders, respiratory ailments, liver and digestive problems, and dermatological complaints. Furthermore, they supply a range of anti-inflammatory and pain-relieving medications. This enterprise, established in 2002, maintains its primary operations in Guangzhou, China. It adopted its current name, ApicHope Pharmaceutical Co., Ltd, in December 2021, having previously been known as Yipinhong Pharmaceutical Co.,Ltd.
- ISIN
- CNE1000035J7
- Founded
- 2002
- Listed since
- Nov 16, 2017
- Exchange
- Shenzhen Stock Exchange
- Currency
- CNY
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.12T | $1,255.40 | +0.88% |
| Johnson & JohnsonNYSE: JNJ | $651.25B | $270.24 | +1.07% |
| Merck & Co., Inc.NYSE: MRK | $376.37B | $152.55 | +2.39% |
| Roche Holding AGSWX: ROP | $373.91B | CHF370.40 | -1.38% |
| Novartis AGSWX: NOVN | $302.17B | CHF127.42 | +0.85% |
| AstraZeneca PLCLSE: AZN | $258.76B | £121.22 | -0.96% |
| Novo Nordisk A/SCPSE: NOVO B | $207.84B | Dkr300.85 | +1.59% |
| Pfizer Inc.NYSE: PFE | $159.99B | $28.07 | +1.01% |
Figures last refreshed Aug 18, 2026.